Doran A - Search Results

1

Effects of long-term bosentan in children with pulmonary arterial hypertension.

Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ. Rosenzweig EB, et al. Among authors: doran a. J Am Coll Cardiol. 2005 Aug 16;46(4):697-704. doi: 10.1016/j.jacc.2005.01.066. J Am Coll Cardiol. 2005. PMID: 16098438 Free article.

2

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH. Ivy DD, et al. J Am Coll Cardiol. 2008 Jan 15;51(2):161-9. doi: 10.1016/j.jacc.2007.09.031. J Am Coll Cardiol. 2008. PMID: 18191742 Free PMC article.

3

Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.

Takatsuki S, Parker DK, Doran AK, Friesen RH, Ivy DD. Takatsuki S, et al. Pediatr Cardiol. 2013 Apr;34(4):1006-12. doi: 10.1007/s00246-012-0597-9. Epub 2012 Nov 27. Pediatr Cardiol. 2013. PMID: 23184020 Free PMC article.

4

Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension.

Barst RJ, Ivy D, Dingemanse J, Widlitz A, Schmitt K, Doran A, Bingaman D, Nguyen N, Gaitonde M, van Giersbergen PL. Barst RJ, et al. Among authors: doran a. Clin Pharmacol Ther. 2003 Apr;73(4):372-82. doi: 10.1016/s0009-9236(03)00005-5. Clin Pharmacol Ther. 2003. PMID: 12709727 Clinical Trial.

5

Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension.

Ivy DD, Parker D, Doran A, Parker D, Kinsella JP, Abman SH. Ivy DD, et al. Among authors: doran a. Am J Cardiol. 2003 Oct 1;92(7):886-90. doi: 10.1016/s0002-9149(03)00910-x. Am J Cardiol. 2003. PMID: 14516902 Clinical Trial.

6

Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.

Ivy DD, Doran A, Claussen L, Bingaman D, Yetman A. Ivy DD, et al. Among authors: doran a. Am J Cardiol. 2004 Apr 1;93(7):943-6. doi: 10.1016/j.amjcard.2003.12.031. Am J Cardiol. 2004. PMID: 15050507 Free PMC article. Clinical Trial.

7

Utility of cardiopulmonary stress testing in assessing disease severity in children with pulmonary arterial hypertension.

Yetman AT, Taylor AL, Doran A, Ivy DD. Yetman AT, et al. Among authors: doran a. Am J Cardiol. 2005 Mar 1;95(5):697-9. doi: 10.1016/j.amjcard.2004.10.056. Am J Cardiol. 2005. PMID: 15721127

8

Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil.

Ivy DD, Claussen L, Doran A. Ivy DD, et al. Among authors: doran a. Am J Cardiol. 2007 Mar 1;99(5):696-8. doi: 10.1016/j.amjcard.2006.09.119. Epub 2007 Jan 10. Am J Cardiol. 2007. PMID: 17317374 Free PMC article.

9

Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.

Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL; Scientific Leadership Council of the Pulmonary Hypertension Association. Doran AK, et al. Int J Clin Pract Suppl. 2008 Jul;(160):5-9. doi: 10.1111/j.1742-1241.2008.01811.x. Int J Clin Pract Suppl. 2008. PMID: 18638170 Free PMC article.

10

Portopulmonary hypertension in pediatric patients.

Condino AA, Ivy DD, O'Connor JA, Narkewicz MR, Mengshol S, Whitworth JR, Claussen L, Doran A, Sokol RJ. Condino AA, et al. Among authors: doran a. J Pediatr. 2005 Jul;147(1):20-6. doi: 10.1016/j.jpeds.2005.02.019. J Pediatr. 2005. PMID: 16027687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters